General Announcement::Partial Redemption of $1,000,000,000 in 4.400% Senior Notes due 2023

Issuer & Securities

Issuer/ Manager
TAKEDA PHARMACEUTICAL COMPANY LIMITED
Securities
TAKEDAPHARUS$1.5B4.4%231126A - US874060AR79 - 8E1B
TAKEDAPHARUS$1.5B4.4%231126R - USJ8129EAX60 - LJLB
TAKEDA US$1.495564B4.4%N231126 - US874060AT36 - EYEB
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
28-Oct-2022 07:58:19
Status
New
Announcement Sub Title
Partial Redemption of $1,000,000,000 in 4.400% Senior Notes due 2023
Announcement Reference
SG221028OTHRGDGU
Submitted By (Co./ Ind. Name)
Izumi Masuyama
Designation
Lead of SEC Reporting
Description (Please provide a detailed description of the event in the box below)
Takeda Pharmaceutical Company Limited redeemed $1,000,000,000 of the total $1,500,000,000 outstanding aggregate principal amount of the 4.400% Senior Notes due 2023 on October 27, 2022. Accordingly, the 2023 Notes redeemed of $1,000,000,000 have been cancelled and an aggregate principal of $500,000,000 of the 2023 Notes will remain outstanding.

Attachments

Takeda_Partial Redemption Notice Senior Notes _October 27 2022.pdf
Total size =134K